Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Barbosa

Showing results (451-460 of 465) with videos related to

Pageof 47
Sort By:
Scientific Reports|January 19, 2024
Microstructural brain abnormalities, fatigue, and cognitive dysfunction after mild COVID-19Lucas Scardua-Silva, Beatriz Amorim da Costa, Ítalo Karmann Aventurato, et al.
Vaccine|December 31, 2021
Exploratory study of humoral and cellular immunity to 17DD Yellow Fever vaccination in children and adults residents of areas without circulation of Yellow Fever VirusLaise Rodrigues Reis, Ismael Artur da Costa-Rocha, Ana Carolina Campi-Azevedo, et al.
Viruses|April 1, 2020
Survey on Non-Human Primates and Mosquitoes Does not Provide Evidences of Spillover/Spillback between the Urban and Sylvatic Cycles of Yellow Fever and Zika Viruses Following Severe Outbreaks in Southeast BrazilFilipe Vieira Santos de Abreu, Anielly Ferreira-de-Brito, Adriana de Souza Azevedo, et al.
Plos Neglected Tropical Diseases|April 9, 2025
Immunogenicity of a single dose of the 17DD yellow fever vaccine in a cohort of adults and children in a non-endemic area, and its association with dengue and Zika seropositivityCamylla Veloso Valença Saucha, Maria de Lourdes de Sousa Maia, Eduardo Sérgio Soares Sousa, et al.
Plos Neglected Tropical Diseases|January 8, 2026
Zika virus infection in early pregnancy increases the likelihood of persistent neutralizing antibodiesEverton Falcão de Oliveira, Amanda Torrentes de Carvalho, Fabio Antonio Venancio, et al.
Scientific Reports|April 2, 2024
Comprehensive landscape of neutralizing antibody and cell-mediated response elicited by the 1/5 fractional dose of 17DD-YF primary vaccination in adultsLaise Rodrigues Reis, Ismael Artur Costa-Rocha, Thais Abdala-Torres, et al.
Pediatrics|January 15, 2025
Early and Long-Term Adverse Outcomes of In Utero Zika ExposureFabio Antonio Venancio, Maria Eulina Quilião, Sanny Cerqueira de Oliveira Gabeira, et al.
International Journal of Epidemiology|August 18, 2025
Evaluating potential associations between prior maternal yellow fever vaccination and protection against infant adverse outcomes following Zika virus antenatal exposureEverton Falcão de Oliveira, Cláudia Du Bocage Santos-Pinto, Fabio Antonio Venancio, et al.
NPJ Vaccines|March 8, 2024
Immune response induced by standard and fractional doses of 17DD yellow fever vaccineThais Abdala-Torres, Ana Carolina Campi-Azevedo, Rosiane Aparecida da Silva-Pereira, et al.
Scientific Reports|May 18, 2021
Serum biomarker profile orchestrating the seroconversion status of patients with autoimmune diseases upon planned primary 17DD Yellow fever vaccinationIsmael Artur da Costa-Rocha, Ketty Lysie Libardi Lira Machado, Ana Carolina Campi-Azevedo, et al.
Pageof 47

Showing results (451-460 of 465) with videos related to

Sort By:
Pageof 47
Scientific Reports|January 19, 2024
Microstructural brain abnormalities, fatigue, and cognitive dysfunction after mild COVID-19Lucas Scardua-Silva, Beatriz Amorim da Costa, Ítalo Karmann Aventurato, et al.
Vaccine|December 31, 2021
Exploratory study of humoral and cellular immunity to 17DD Yellow Fever vaccination in children and adults residents of areas without circulation of Yellow Fever VirusLaise Rodrigues Reis, Ismael Artur da Costa-Rocha, Ana Carolina Campi-Azevedo, et al.
Viruses|April 1, 2020
Survey on Non-Human Primates and Mosquitoes Does not Provide Evidences of Spillover/Spillback between the Urban and Sylvatic Cycles of Yellow Fever and Zika Viruses Following Severe Outbreaks in Southeast BrazilFilipe Vieira Santos de Abreu, Anielly Ferreira-de-Brito, Adriana de Souza Azevedo, et al.
Plos Neglected Tropical Diseases|April 9, 2025
Immunogenicity of a single dose of the 17DD yellow fever vaccine in a cohort of adults and children in a non-endemic area, and its association with dengue and Zika seropositivityCamylla Veloso Valença Saucha, Maria de Lourdes de Sousa Maia, Eduardo Sérgio Soares Sousa, et al.
Plos Neglected Tropical Diseases|January 8, 2026
Zika virus infection in early pregnancy increases the likelihood of persistent neutralizing antibodiesEverton Falcão de Oliveira, Amanda Torrentes de Carvalho, Fabio Antonio Venancio, et al.
Scientific Reports|April 2, 2024
Comprehensive landscape of neutralizing antibody and cell-mediated response elicited by the 1/5 fractional dose of 17DD-YF primary vaccination in adultsLaise Rodrigues Reis, Ismael Artur Costa-Rocha, Thais Abdala-Torres, et al.
Pediatrics|January 15, 2025
Early and Long-Term Adverse Outcomes of In Utero Zika ExposureFabio Antonio Venancio, Maria Eulina Quilião, Sanny Cerqueira de Oliveira Gabeira, et al.
International Journal of Epidemiology|August 18, 2025
Evaluating potential associations between prior maternal yellow fever vaccination and protection against infant adverse outcomes following Zika virus antenatal exposureEverton Falcão de Oliveira, Cláudia Du Bocage Santos-Pinto, Fabio Antonio Venancio, et al.
NPJ Vaccines|March 8, 2024
Immune response induced by standard and fractional doses of 17DD yellow fever vaccineThais Abdala-Torres, Ana Carolina Campi-Azevedo, Rosiane Aparecida da Silva-Pereira, et al.
Scientific Reports|May 18, 2021
Serum biomarker profile orchestrating the seroconversion status of patients with autoimmune diseases upon planned primary 17DD Yellow fever vaccinationIsmael Artur da Costa-Rocha, Ketty Lysie Libardi Lira Machado, Ana Carolina Campi-Azevedo, et al.
Pageof 47